RxDoctor Payments Data

Tatiana Iler

Psychiatric/Mental Health · Fort Pierce, FLNPI 1942881297

Payments from drug & device makers

$3,186in general payments, 2019–2025

Across 144 payments — averaging $22.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$991
  • Teva Pharmaceuticals USA, Inc.$652
  • Alkermes, Inc.$426
  • Neurocrine Biosciences, Inc.$376
  • Otsuka America Pharmaceutical, Inc.$267
  • Johnson & Johnson$245
  • plus $229 from 6 others

What the payments were for

  • Food & beverage$3,186100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,186 in reported general payments places this provider in the 80th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$3,408
Medicare patients
29
Services billed
37

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl24$38,659
Clozapine197$17,645
Paliperidone ErPaliperidone11$3,901
Trazodone Hcl22$844
Haloperidol Decanoate14$644
Quetiapine Fumarate28$631
Haloperidol27$623
Ziprasidone Hcl14$553
Glycopyrrolate25$519
Divalproex Sodium ErDivalproex Sodium15$468
Risperidone57$439
Hydroxyzine Pamoate13$376
Fluoxetine Hcl38$367
Benztropine Mesylate39$349
Venlafaxine Hcl ErVenlafaxine Hcl22$277

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$991$38,65924 claims
Almatica Pharma LLCSertraline Hcl$22$15915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Fort Pierce

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →